NHS Overview

Neuberger Berman High Yield Strategies Fund Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund seeks a high total return (income plus capital appreciation). The Fund will normally invest at least 80% of its total assets in high yield debt securities of United States and foreign issuers, which include securities that are rated below investment grade by a rating agency or are unrated debt securities determined to be of comparable quality by the Fund’s investment manager. It invests in various sectors, including agriculture, airlines, auto manufacturers, biotechnology, building materials, chemicals, commercial services, electric, energy-alternate sources, engineering and construction, entertainment, healthcare-products, healthcare, insurance, iron-steel, machinery-construction and mining and others. The Fund’s investment manager and administrator is Neuberger Berman Investment Advisers LLC.

Wall Street analysts forecast NHS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NHS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Neuberger Berman High Yield Strategies Fund revenue for the last quarter amounts to NaN USD, decreased

Neuberger Berman High Yield Strategies Fund. EPS for the last quarter amounts to USD, decreased

Neuberger Berman High Yield Strategies Fund (NHS) has 0 emplpoyees as of March 31 2026.

Today NHS has the market capitalization of 0.00 USD.